Back

The Patch BRIDGE trial

Official Title

Using the Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy: A Randomized Controlled Trial

Study Details

The purpose of the study is to show that buprenorphine patches (microdoses) are an effective method to initiate in obstetric patients with opioid disorder.

Principal Investigator

Jeannie Kelly

IRB Number

202209093

Eligibility

1. Must be age 18 or older
2. Must have a confirmed viable intrauterine pregnancy at any gestational age or within 6 weeks of delivery
3. Must have an active opioid use disorder

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back